NEW YORK (GenomeWeb) – Startup Shoreline Biome announced today that it has raised $1.1 million in equity funding from venture capital firm Connecticut Innovations and undisclosed independent investors.
The company — which is based at the University of Connecticut's Technology Incubation Program in Farmington, Connecticut — said it would use the funding to continue development of its kits, protocols, and software for the identification and quantification of bacteria in the human microbiome.
"We have designed a suite of polymerase chain reaction targets that tailor the assay to the needs of the researcher, including the ability to generate a PCR product capable of identifying organisms at the subspecies level," Shoreline CEO Tom Jarvie said in a statement. He added that the company's analysis software demultiplexes samples after sequencing and provides a view of the organisms present in the samples.
The company was founded in June 2015 by Jarvie and CSO Mark Driscoll, both former employees of Roche/454 Life Sciences.